(Q41018593)

25 September 2017

1 reference

title

The use of beta 2-adrenoceptor agonists in the treatment of bronchial asthma (English)

1 reference

25 September 2017

1 reference

Svedmyr N

1

1 reference

25 September 2017

Löfdahl CG

series ordinal

2

1 reference

25 September 2017

publication date

1 January 1996

1 reference

Basic and Clinical Pharmacology and Toxicology

25 September 2017

published in

1 reference

25 September 2017

volume

78

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

3-11

1 reference

Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1996.TB00172.X

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1996.TB00172.X

Salmeterol: an inhaled beta 2-agonist with prolonged duration of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1996.TB00172.X

Regular Inhaled Beta-Adrenergic Agonists in the Treatment of Bronchial Asthma: Beneficial or Detrimental?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1996.TB00172.X

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1996.TB00172.X

Asthma control during and after cessation of regular beta 2-agonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0773.1996.TB00172.X

10.1111/J.1600-0773.1996.TB00172.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference